STSSW | Sharps Technology, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0500 - 0.0501
52 Week Range	0.0500 - 0.0501
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	61,821
Average Volume	N/A
Shares Outstanding	103,054,091
Market Cap	5,152,706
Sector	Financial Services
Industry	Financial - Capital Markets
IPO Date	2022-04-14

Valuation
Profitability
Growth
Health
P/E Ratio	-0.05
Forward P/E Ratio	N/A
EPS	-0.96
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	57
Country	USA
Website	STSSW

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

STSSW's peers: STSS, TNON, SPRC, OKYO, GBNH, SVREW, RVSNW, LUCYW, JFBRW

*Chart delayed

Analyzing fundamentals for STSSW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see STSSW Fundamentals page.

Watching at STSSW technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on STSSW Technicals page.